1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chloramphenicol 1.2.3 Beta Lactums 1.2.4 Quinolones 1.2.5 Aminoglycosides 1.2.6 Others 1.3 Market by Application 1.3.1 Global Intra-abdominal Infection Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Intra-abdominal Abscess 1.3.3 Appendicitis 1.3.4 Diverticulitis 1.3.5 Diarrhea 1.3.6 Food Poisoning 1.3.7 Infection by Helicobacter Pylori 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Intra-abdominal Infection Treatment Drugs Market Perspective (2016-2027) 2.2 Intra-abdominal Infection Treatment Drugs Growth Trends by Regions 2.2.1 Intra-abdominal Infection Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Intra-abdominal Infection Treatment Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Intra-abdominal Infection Treatment Drugs Industry Dynamic 2.3.1 Intra-abdominal Infection Treatment Drugs Market Trends 2.3.2 Intra-abdominal Infection Treatment Drugs Market Drivers 2.3.3 Intra-abdominal Infection Treatment Drugs Market Challenges 2.3.4 Intra-abdominal Infection Treatment Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Intra-abdominal Infection Treatment Drugs Players by Revenue 3.1.1 Global Top Intra-abdominal Infection Treatment Drugs Players by Revenue (2016-2021) 3.1.2 Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Intra-abdominal Infection Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Intra-abdominal Infection Treatment Drugs Revenue 3.4 Global Intra-abdominal Infection Treatment Drugs Market Concentration Ratio 3.4.1 Global Intra-abdominal Infection Treatment Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Intra-abdominal Infection Treatment Drugs Revenue in 2020 3.5 Intra-abdominal Infection Treatment Drugs Key Players Head office and Area Served 3.6 Key Players Intra-abdominal Infection Treatment Drugs Product Solution and Service 3.7 Date of Enter into Intra-abdominal Infection Treatment Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Intra-abdominal Infection Treatment Drugs Breakdown Data by Type 4.1 Global Intra-abdominal Infection Treatment Drugs Historic Market Size by Type (2016-2021) 4.2 Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2022-2027) 5 Intra-abdominal Infection Treatment Drugs Breakdown Data by Application 5.1 Global Intra-abdominal Infection Treatment Drugs Historic Market Size by Application (2016-2021) 5.2 Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Intra-abdominal Infection Treatment Drugs Market Size (2016-2027) 6.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Type 6.2.1 North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) 6.2.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) 6.2.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027) 6.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Application 6.3.1 North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) 6.3.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) 6.3.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027) 6.4 North America Intra-abdominal Infection Treatment Drugs Market Size by Country 6.4.1 North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) 6.4.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Intra-abdominal Infection Treatment Drugs Market Size (2016-2027) 7.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type 7.2.1 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) 7.2.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) 7.2.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027) 7.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application 7.3.1 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) 7.3.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) 7.3.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027) 7.4 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country 7.4.1 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) 7.4.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size (2016-2027) 8.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type 8.2.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application 8.3.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region 8.4.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size (2016-2027) 9.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type 9.2.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027) 9.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application 9.3.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027) 9.4 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country 9.4.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size (2016-2027) 10.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type 10.2.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application 10.3.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country 10.4.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca Intra-abdominal Infection Treatment Drugs Introduction 11.1.4 AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.1.5 AstraZeneca Recent Development 11.2 Merck 11.2.1 Merck Company Details 11.2.2 Merck Business Overview 11.2.3 Merck Intra-abdominal Infection Treatment Drugs Introduction 11.2.4 Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.2.5 Merck Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Intra-abdominal Infection Treatment Drugs Introduction 11.3.4 Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 AtoxBio 11.4.1 AtoxBio Company Details 11.4.2 AtoxBio Business Overview 11.4.3 AtoxBio Intra-abdominal Infection Treatment Drugs Introduction 11.4.4 AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.4.5 AtoxBio Recent Development 11.5 Dainippon Sumitomo Pharma 11.5.1 Dainippon Sumitomo Pharma Company Details 11.5.2 Dainippon Sumitomo Pharma Business Overview 11.5.3 Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Introduction 11.5.4 Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.5.5 Dainippon Sumitomo Pharma Recent Development 11.6 Bayer 11.6.1 Bayer Company Details 11.6.2 Bayer Business Overview 11.6.3 Bayer Intra-abdominal Infection Treatment Drugs Introduction 11.6.4 Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.6.5 Bayer Recent Development 11.7 Bristol-Myers Squibb 11.7.1 Bristol-Myers Squibb Company Details 11.7.2 Bristol-Myers Squibb Business Overview 11.7.3 Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Introduction 11.7.4 Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.7.5 Bristol-Myers Squibb Recent Development 11.8 Mylan Pharmaceuticals Inc. 11.8.1 Mylan Pharmaceuticals Inc. Company Details 11.8.2 Mylan Pharmaceuticals Inc. Business Overview 11.8.3 Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Introduction 11.8.4 Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.8.5 Mylan Pharmaceuticals Inc. Recent Development 11.9 Sun Pharmaceutical Industries, Inc. 11.9.1 Sun Pharmaceutical Industries, Inc. Company Details 11.9.2 Sun Pharmaceutical Industries, Inc. Business Overview 11.9.3 Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Introduction 11.9.4 Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.9.5 Sun Pharmaceutical Industries, Inc. Recent Development 11.10 Teva Pharmaceutical Industries 11.10.1 Teva Pharmaceutical Industries Company Details 11.10.2 Teva Pharmaceutical Industries Business Overview 11.10.3 Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Introduction 11.10.4 Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.10.5 Teva Pharmaceutical Industries Recent Development 11.11 Dr. Reddy’s Laboratories 11.11.1 Dr. Reddy’s Laboratories Company Details 11.11.2 Dr. Reddy’s Laboratories Business Overview 11.11.3 Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Introduction 11.11.4 Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.11.5 Dr. Reddy’s Laboratories Recent Development 11.12 Roche Holding AG 11.12.1 Roche Holding AG Company Details 11.12.2 Roche Holding AG Business Overview 11.12.3 Roche Holding AG Intra-abdominal Infection Treatment Drugs Introduction 11.12.4 Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.12.5 Roche Holding AG Recent Development 11.13 GlaxoSmithKline 11.13.1 GlaxoSmithKline Company Details 11.13.2 GlaxoSmithKline Business Overview 11.13.3 GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Introduction 11.13.4 GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.13.5 GlaxoSmithKline Recent Development 11.14 Sanofi 11.14.1 Sanofi Company Details 11.14.2 Sanofi Business Overview 11.14.3 Sanofi Intra-abdominal Infection Treatment Drugs Introduction 11.14.4 Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) 11.14.5 Sanofi Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chloramphenicol Table 3. Key Players of Beta Lactums Table 4. Key Players of Quinolones Table 5. Key Players of Aminoglycosides Table 6. Key Players of Others Table 7. Global Intra-abdominal Infection Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Intra-abdominal Infection Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Intra-abdominal Infection Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions (2016-2021) Table 11. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions (2022-2027) Table 13. Intra-abdominal Infection Treatment Drugs Market Trends Table 14. Intra-abdominal Infection Treatment Drugs Market Drivers Table 15. Intra-abdominal Infection Treatment Drugs Market Challenges Table 16. Intra-abdominal Infection Treatment Drugs Market Restraints Table 17. Global Intra-abdominal Infection Treatment Drugs Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Intra-abdominal Infection Treatment Drugs Market Share by Players (2016-2021) Table 19. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2020) Table 20. Ranking of Global Top Intra-abdominal Infection Treatment Drugs Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Intra-abdominal Infection Treatment Drugs Product Solution and Service Table 24. Date of Enter into Intra-abdominal Infection Treatment Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 27. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2016-2021) Table 28. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Intra-abdominal Infection Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2016-2021) Table 32. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 35. North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 37. North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 64. AstraZeneca Company Details Table 65. AstraZeneca Business Overview Table 66. AstraZeneca Intra-abdominal Infection Treatment Drugs Product Table 67. AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 68. AstraZeneca Recent Development Table 69. Merck Company Details Table 70. Merck Business Overview Table 71. Merck Intra-abdominal Infection Treatment Drugs Product Table 72. Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 73. Merck Recent Development Table 74. Pfizer Company Details Table 75. Pfizer Business Overview Table 76. Pfizer Intra-abdominal Infection Treatment Drugs Product Table 77. Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 78. Pfizer Recent Development Table 79. AtoxBio Company Details Table 80. AtoxBio Business Overview Table 81. AtoxBio Intra-abdominal Infection Treatment Drugs Product Table 82. AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 83. AtoxBio Recent Development Table 84. Dainippon Sumitomo Pharma Company Details Table 85. Dainippon Sumitomo Pharma Business Overview Table 86. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Product Table 87. Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 88. Dainippon Sumitomo Pharma Recent Development Table 89. Bayer Company Details Table 90. Bayer Business Overview Table 91. Bayer Intra-abdominal Infection Treatment Drugs Product Table 92. Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 93. Bayer Recent Development Table 94. Bristol-Myers Squibb Company Details Table 95. Bristol-Myers Squibb Business Overview Table 96. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Product Table 97. Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 98. Bristol-Myers Squibb Recent Development Table 99. Mylan Pharmaceuticals Inc. Company Details Table 100. Mylan Pharmaceuticals Inc. Business Overview Table 101. Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 102. Mylan Pharmaceuticals Inc. Recent Development Table 103. Sun Pharmaceutical Industries, Inc. Company Details Table 104. Sun Pharmaceutical Industries, Inc. Business Overview Table 105. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Product Table 106. Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 107. Sun Pharmaceutical Industries, Inc. Recent Development Table 108. Teva Pharmaceutical Industries Company Details Table 109. Teva Pharmaceutical Industries Business Overview Table 110. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Product Table 111. Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 112. Teva Pharmaceutical Industries Recent Development Table 113. Dr. Reddy’s Laboratories Company Details Table 114. Dr. Reddy’s Laboratories Business Overview Table 115. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Product Table 116. Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 117. Dr. Reddy’s Laboratories Recent Development Table 118. Roche Holding AG Company Details Table 119. Roche Holding AG Business Overview Table 120. Roche Holding AG Intra-abdominal Infection Treatment Drugs Product Table 121. Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 122. Roche Holding AG Recent Development Table 123. GlaxoSmithKline Company Details Table 124. GlaxoSmithKline Business Overview Table 125. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Product Table 126. GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 127. GlaxoSmithKline Recent Development Table 128. Sanofi Company Details Table 129. Sanofi Business Overview Table 130. Sanofi Intra-abdominal Infection Treatment Drugs Product Table 131. Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million) Table 132. Sanofi Recent Development Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Global Intra-abdominal Infection Treatment Drugs Market Share by Type: 2020 VS 2027 Figure 2. Chloramphenicol Features Figure 3. Beta Lactums Features Figure 4. Quinolones Features Figure 5. Aminoglycosides Features Figure 6. Others Features Figure 7. Global Intra-abdominal Infection Treatment Drugs Market Share by Application: 2020 VS 2027 Figure 8. Intra-abdominal Abscess Case Studies Figure 9. Appendicitis Case Studies Figure 10. Diverticulitis Case Studies Figure 11. Diarrhea Case Studies Figure 12. Food Poisoning Case Studies Figure 13. Infection by Helicobacter Pylori Case Studies Figure 14. Intra-abdominal Infection Treatment Drugs Report Years Considered Figure 15. Global Intra-abdominal Infection Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Intra-abdominal Infection Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions: 2020 VS 2027 Figure 18. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions (2022-2027) Figure 19. Global Intra-abdominal Infection Treatment Drugs Market Share by Players in 2020 Figure 20. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue in 2020 Figure 22. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2016-2021) Figure 23. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2022-2027) Figure 24. North America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027) Figure 26. North America Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027) Figure 27. North America Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027) Figure 28. United States Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027) Figure 32. Europe Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027) Figure 33. Europe Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027) Figure 34. Germany Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027) Figure 42. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027) Figure 43. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Region (2016-2027) Figure 44. China Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027) Figure 52. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027) Figure 53. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027) Figure 54. Mexico Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027) Figure 58. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027) Figure 59. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027) Figure 60. Turkey Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. AstraZeneca Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 64. Merck Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 65. Pfizer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 66. AtoxBio Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 67. Dainippon Sumitomo Pharma Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 68. Bayer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 70. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 71. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 72. Teva Pharmaceutical Industries Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 73. Dr. Reddy’s Laboratories Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 74. Roche Holding AG Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 75. GlaxoSmithKline Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 76. Sanofi Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

AstraZeneca Merck Pfizer AtoxBio Dainippon Sumitomo Pharma Bayer Bristol-Myers Squibb Mylan Pharmaceuticals Inc. Sun Pharmaceutical Industries, Inc. Teva Pharmaceutical Industries Dr. Reddy’s Laboratories Roche Holding AG GlaxoSmithKline Sanofi